Publications

Nicolas CAPET

• Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone-A Case Report. Capet N, Levraut M, Delourme A, Thomel-Rocchi O, Bourg V, Cabre P, Vandenbos F, Mondot L, Lebrun-Frenay C. Neurol Ther. 2022 Mar;11(1):507-513. doi: 10.1007/s40120-021-00308-6.
• Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion. Héraud C, Capet N, Levraut M, Hattenberger R, Bourg V, Thomas P, Mondot L, Lebrun-Frenay C. Neurol Ther. 2022 Mar;11(1):499-505. doi: 10.1007/s40120-021-00302-y.
• Cerebrospinal Fluid IL-17A Could Predict Acute Disease Severity in Non-NMDA-Receptor Autoimmune Encephalitis. Levraut M, Bourg V, Capet N, Delourme A, Honnorat J, Thomas P, Lebrun-Frenay C. Front Immunol. 2021 May 13;12:673021. doi: 10.3389/fimmu.2021.673021.
• Alexithymia in multiple sclerosis: Clinical and radiological correlations. Capet N, Joly H, Suply C, Mondot L, Cohen M, Lebrun-Frenay C.Rev Neurol (Paris). 2021 Mar;177(3):302-311. doi: 10.1016/j.neurol.2020.06.008.
• Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis. Joly H, Capet N, Mondot L, Cohen M, Suply C, Bresch S, Lebrun-Frenay C. Mult Scler Relat Disord. 2020 Sep;44:102374. doi: 10.1016/j.msard.2020.102374.
• Voxel-based assessments of treatment effects on longitudinal brain changes in the Multidomain Alzheimer Preventive Trial cohort. Sivera R, Capet N, Manera V, Fabre R, Lorenzi M, Delingette H, Pennec X, Ayache N, Robert P; MAPT/DSA Group. Neurobiol Aging. 2020 Oct;94:50-59. doi: 10.1016/j.neurobiolaging.2019.11.020.

Renaud DAVID

• Connectivity patterns of the core resting-state networks associated with apathy in late-life depression. Roy JC, Desmidt T, Dam S, Mirea-Grivel I, Weyl L, Bannier E, Barantin L, Drapier D, Batail JM, David R, Coloigner J, Robert GH. J Psychiatry Neurosci. 2023 Nov 1;48(6):E404-E413. doi: 10.1503/jpn.230008. Print 2023 Nov-Dec.
• Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.  Bogdan A, Fabre R, Desmidt T, Golebiowski J, Topin J, Bethus I, Hanon O, Boutoleau-Bretonniere C, Wagemann N, Annweiler C, Ousset PJ, Godefroy O, Rouch I, Paccalin M, Sukhorukova M, Gabelle A, Robert G, David R; Memento Group. J Alzheimers Dis. 2023 Aug 1.

• Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort. Grasset L, Planche V, Bouteloup V, Azouani C, Dubois B, Blanc F, Paquet C, David R, Belin C, Jonveaux T, Julian A, Pariente J, Mangin JF, Chêne G, Dufouil C; Memento Cohort Study Group. Alzheimers Dement. 2023 Jul 8. doi: 10.1002/alz.13360.
• Assessing the pool activity level (PAL) checklist for use with people with hearing and vision loss. Dawes P, Pool J, Charalambous AP, Côté M, David R, Helmer C, Laforce R, Politis A, Russell G, Sirois MJ, Thodi C, Yeung WK, Leroi I. Geriatr Nurs. 2023 Jun 30;53:1-5. doi: 10.1016/j.gerinurse.2023.06.001.
• Development and validation of the Montreal cognitive assessment for people with hearing impairment (MoCA-H). Dawes P, Reeves D, Yeung WK, Holland F, Charalambous AP, Côté M, David R, Helmer C, Laforce R, Martins RN, Politis A, Pye A, Russell G, Sheikh S, Sirois MJ, Sohrabi HR, Thodi C, Gallant K, Nasreddine Z, Leroi I.J Am Geriatr Soc. 2023 Feb 1. doi: 10.1111/jgs.18241
• Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort. Blanc F, Bouteloup V, Paquet C, Chupin M, Pasquier F, Gabelle A, Ceccaldi M, de Sousa PL, Krolak-Salmon P, David R, Fischer C, Dartigues JF, Wallon D, Moreaud O, Sauvée M, Belin C, Harston S, Botzung A et al., Alzheimers Res Ther. 2022 Jul 19;14(1):96. · 19 juil. 2022
• Top-down and bottom-up sources of eye-movement guidance during realistic scene search in Alzheimer’s disease. Ramzaoui H, Faure S, David R, Spotorno S. Neuropsychology. 2022 Jul 7. doi: 10.1037/neu0000797. · 7 juil. 2022
• Examining the Relationships between Mindfulness and Tobacco Craving Factors. Barré T, Ramier C, Mounir I, David R, Menvielle L, Marcellin F, Carrieri P, Protopopescu C, Cherikh F. Subst Use Misuse. 2022;57(4):656-659.
• Multimodal MRI cerebral correlates of verbal fluency switching and its impairment in women with depression. Domain L, Guillery M, Linz N, König A, Batail JM, David R, Corouge I, Bannier E, Ferré JC, Dondaine T, Drapier D, Robert GH. Neuroimage Clin. 2022;33:102910.
• Mindfulness as a Protective Factor Against Increased Tobacco and Alcohol Use in Hospital Workers Following the First COVID-19-Related Lockdown: a Study in Southern France. Barré T, Ramier C, Mounir I, David R, Menvielle L, Marcellin F, Carrieri P, Protopopescu C, Cherikh F. Int J Ment Health Addict. 2022 Jan 23:1-21. · 23 janv. 2022
• Benzodiazepine use and neuroimaging markers of Alzheimer’s disease in nondemented older individuals: an MRI and 18F Florbetapir PET study in the MEMENTO cohort. Gallet Q, Bouteloup V, Locatelli M, Habert MO, Chupin M, Delrieu J, Lebouvier T, Robert G, David R, Bulteau S, Balageas AC, Surget A, Belzung C, El-Hage W, Camus V, Gohier B, Desmidt T; MEMENTO study group. Neuropsychopharmacology. 2021 Dec 10. · 10 déc. 2021
• Psychological Distress and Tobacco Use Among Hospital Workers During COVID-19. Mounir I, Menvielle L, Perlaza S, Chênevert D, Planchard JH, Fabre R, Benoit M, Benyamina A, Rolland B, Cherikh F, David R. Front Psychiatry. 2021 Jul 28;12:701810. · 28 juil. 2021
• Support care needs of people with hearing and vision impairment in dementia: a European cross-national perspective. Leroi, I ; Wolski, L ; Charalambous, AP ; Constantinidou, F ; David, R ; Dawes, P & al. Disabil Rehabil. 2021, 1-13. · 1 juil. 2021
• Smell and taste changes are early indicators of the COVID-19 pandemic and political decision effectiveness. Pierron D, Pereda-Loth V, Mantel M, Moranges M, Bignon E, Alva O, Kabous J, Heiske M, Pacalon J, David R, Sell EA, Thomas-Danguin T, Bakke AJ, Parma V, Hayes JE, Letellier T, Ferdenzi C, Golebiowski J, Bensafi M. Nat Commun. 2020 Oct 14;11(1):5152.
• Mindfulness meditation for family caregivers. Filleau C, David R, Robert P. Soins Gerontol. 2020 Sep-Oct;25(145):40-45. · 1 sept. 2020
• Subjective cognitive and non-cognitive complaints and brain MRI biomarkers in the MEMENTO cohort. Dauphinot V et al., Alzheimers Dement (Amst). 2020 Jul 5;12(1):e12051. · 5 juil. 2020
• Pathways to care for people with dementia: An international multicentre study. Volpe et al., Int J Geriatr Psychiatry. 2020 Feb;35(2):163-173.
• Pharmacologic Approaches for the Management of Apathy in Neurodegenerative Disorders. Bogdan A, Manera V, Koenig A, David R. Front Pharmacol. 2020 Jan 23;10:1581. doi: 10.3389/fphar.2019.01581. eCollection 2019. · 23 janv. 2020
• Absence of Relationship Between Self-Reported Sleep Measures and Amyloid Load in Elderly Subjects. Gabelle A et al., Front Neurol. 2019 Sep 13;10:989. doi: 10.3389/fneur.2019.00989. eCollection 2019. · 13 sept. 2019
• Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the Multidomain Alzheimer Preventive Trial cohort. Desmidt T et al., MAPT/DSA study group. Neurobiol Aging. 2019 Aug 14;84:61-69. doi: 10.1016/j.neurobiolaging.2019.08.008. · 14 août 2019
• Recommendations for the Nonpharmacological Treatment of Apathy in Brain Disorders. Manera V et al., Am J Geriatr Psychiatry. 2019 Aug 9. pii: S1064-7481(19)30459-2. doi: 10.1016/j.jagp.2019.07.014
• Relationships between objectives sleep parameters and brain amyloid load in subjects at risk to Alzheimer’s disease: the INSIGHT-preAD Study. Ettore E, Bakardjian H, Solé M, Levy Nogueira M, Habert MO, Gabelle A, Dubois B, Robert P, David R. Sleep. 2019 Jul 2. pii: zsz137. doi: 10.1093/sleep/zsz137.
• How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years. Epelbaum S et al., BMJ Open. 2019 Jun 24;9(6):e029663. doi: 10.1136/bmjopen-2019-029663.
• Alzheimer’s disease: Estimating its prevalence rate in a French geographical unit using the National Alzheimer Data Bank and national health insurance information systems. Bailly L, David R, Chevrier R, Grebet J, Moncada M, Fuch A, Sciortino V, Robert P, Pradier C. PLoS One. 2019 May 6;14(5):e0216221. doi: 10.1371/journal.pone.0216221. · 6 mai 2019
• Sex ratio in dementia with Lewy bodies balanced between Alzheimer’s disease and Parkinson’s disease dementia: a cross-sectional study. Mouton A, Blanc F, Gros A, Manera V, Fabre R, Sauleau E, Gomez-Luporsi I, Tifratene K, Friedman L, Thümmler S, Pradier C, Robert PH, David R. Alzheimers Res Ther. 2018 Sep 12;10(1):92. doi: 10.1186/s13195-018-0417-4.
• Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group. Robert P et al., Eur Psychiatry. 2018 Oct;54:71-76. doi: 10.1016/j.eurpsy.2018.07.008. Epub 2018 Aug 17.
• Use of Speech Analyses within a Mobile Application for the Assessment of Cognitive Impairment in Elderly People. Konig A, Satt A, Sorin A, Hoory R, Derreumaux A, David R, Robert PH. Curr Alzheimer Res. 2018;15(2):120-129. doi: 10.2174/1567205014666170829111942. · 1 juin 2018
• Neural correlates of episodic memory in the Memento cohort. Epelbaum S et al., Alzheimers Dement (N Y). 2018 May 22;4:224-233. doi: 10.1016/j.trci.2018.03.010. eCollection 2018. · 22 mai 2018
• Pharmacoresistant Severe Mental Health Disorders in Children and Adolescents: Functional Abnormalities of Cytochrome P450 2D6. Thümmler S, Dor E, David R, Leali G, Battista M, David A, Askenazy F, Verstuyft C. Front Psychiatry. 2018 Jan 24;9:2. doi: 10.3389/fpsyt.2018.00002. eCollection 2018. · 24 janv. 2018
• Objective measurement of gait parameters in healthy and cognitively impaired elderly using the dual-task paradigm. König A, Klaming L, Pijl M, Demeurraux A, David R, Robert P. Aging Clin Exp Res. 2017 Dec;29(6):1181-1189. doi: 10.1007/s40520-016-0703-6. Epub 2017 Jan 27. · 1 déc. 2017
• Excessive Sleepiness and Longer Nighttime in Bed Increase the Risk of Cognitive Decline in Frail Elderly Subjects: The MAPT-Sleep Study. Gabelle A, Gutierrez LA, Jaussent I, Navucet S, Grasselli C, Bennys K, Marelli C, David R, Andrieu S, Berr C, Vellas B, Dauvilliers Y. Front Aging Neurosci. 2017 Sep 28;9:312. doi: 10.3389/fnagi.2017.00312. eCollection 2017.
• Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort. Dufouil C et al., MEMENTO cohort Study Group. Alzheimers Res Ther. 2017 Aug 29;9(1):67. doi: 10.1186/s13195-017-0288-0. · 29 août 2017
• Recommendations for the Use of Serious Games in Neurodegenerative Disorders: 2016 Delphi Panel. Manera V, Ben-Sadoun G, Aalbers T, Agopyan H, Askenazy F, Benoit M, Bensamoun D, Bourgeois J, Bredin J, Bremond F, Crispim-Junior C, David R et al., Front Psychol. 2017 Jul 25;8:1243. doi: 10.3389/fpsyg.2017.01243. eCollection 2017.
• Antipsychotic prescribing for Alzheimer’s disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study. Tifratene K, Manera V, Fabre R, Gros A, Thummler S, Pradier C, Robert P, David R. Alzheimers Res Ther. 2017 Apr 26;9(1):34. doi: 10.1186/s13195-017-0256-8. · 26 avr. 2017
• Olfactory disturbances in ageing with and without dementia: towards new diagnostic tools. Gros A, Manera V, De March CA, Guevara N, König A, Friedman L, Robert P, Golebiowski J, David R. J Laryngol Otol. 2017 Jul;131(7):572-579. doi: 10.1017/S0022215117000858. Epub 2017 Apr 20.
• Recommendations for the Use of ICT in Elderly Populations with Affective Disorders. Gros A, Bensamoun D, Manera V, Fabre R, Zacconi-Cauvin AM, Thummler S, Benoit M, Robert P, David R. Front Aging Neurosci. 2016 Nov 8;8:269. eCollection 2016.
• Neuropsychiatric disorders and technological solutions. Bensamoun D, Gros A, Manera V, König A, Guérin O, Robert P, David R. Soins Gerontol. 2016 Sep-Oct;21(121):18-20. doi: 10.1016/j.sger.2016.07.005. French.
• Robotics and improvement of the quality of geriatric care. Ettore É, Wyckaert E, David R, Robert P, Guérin O, Prate F. Soins Gerontol. 2016 Sep-Oct;21(121):15-17. doi: 10.1016/j.sger.2016.07.004. French.
• [Serious game, a link between institution and home]. Robert P, Manera V, Brousse J, Bourgeois J, Foulon P, David R. Soins Gerontol. 2016 Sep-Oct;21(121):24-26. doi: 10.1016/j.sger.2016.07.007. French.
• Evolution of the Antidepressant Prescribing in Alzheimer’s Disease and Related Disorders Between 2010 and 2014: Results from the French National Database on Alzheimer’s Disease (BNA). David R, Manera V, Fabre R, Pradier C, Robert P, Tifratene K. J Alzheimers Dis. 2016 Jul 2;53(4):1365-73. doi: 10.3233/JAD-160238. · 2 juil. 2016
• Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People. Bensamoun D, Guignard R, Furst AJ, Derreumaux A, Manera V, Darcourt J, Benoit M, Robert PH, David R. J Alzheimers Dis. 2016;49(2):387-98. doi: 10.3233/JAD-150181. · 1 mai 2016
• A Feasibility Study with Image-Based Rendered Virtual Reality in Patients with Mild Cognitive Impairment and Dementia. Manera V, Chapoulie E, Bourgeois J, Guerchouche R, David R, Ondrej J, Drettakis G, Robert P. PLoS One. 2016 Mar 18;11(3):e0151487. doi: 10.1371/journal.pone.0151487. eCollection 2016. · 18 mars 2016
• Characteristics of Alzheimer’s Disease Patients with Severe Executive Disorders. Godefroy O, Bakchine S, Verny M, Delabrousse-Mayoux JP, Roussel M, Pere JJ; REFLEX study group:. J Alzheimers Dis. 2016;51(3):815-25. doi: 10.3233/JAD-150971. · 1 mars 2016
• Exercise Plus Cognitive Performance Over and Above Exercise Alone in Subjects with Mild Cognitive Impairment. Sacco G, Caillaud C, Ben Sadoun G, Robert P, David R, Brisswalter J. J Alzheimers Dis. 2016;50(1):19-25. doi: 10.3233/JAD-150194.
• Alzheimer’s disease and the organization of visits to cultural sites. Lafont V, Brinck-Jensen S, Filleau C, Greenblat C, David R, Robert P. Soins Gerontol. 2015 Jul-Aug;(114):39-42. doi: 10.1016/j.sger.2015.03.012. French.
• Frequency and coding of psychiatric care of short-stay patients. Bourdais-Mannone C, Gendreike Y, Clamen A, Teadi J, Jover F, David R, Cherikh F, Staccini P. Sante Publique. 2015 Mar-Apr;27(2):221-31. French.
• ‘Kitchen and cooking,’ a serious game for mild cognitive impairment and Alzheimer’s disease: a pilot study. Manera V, Petit PD, Derreumaux A, Orvieto I, Romagnoli M, Lyttle G, David R, Robert PH. Front Aging Neurosci. 2015 Mar 17;7:24. doi: 10.3389/fnagi.2015.00024. eCollection 2015. · 15 mars 2015
• Automatic speech analysis for the assessment of patients with predementia and Alzheimer’s disease. König A, Satt A, Sorin A, Hoory R, Toledo-Ronen O, Derreumaux A, Manera V, Verhey F, Aalten P, Robert PH, David R. Alzheimers Dement (Amst). 2015 Mar 29;1(1):112-24. doi: 10.1016/j.dadm.2014.11.012. eCollection 2015 Mar. · 1 mars 2015
• Ecological Assessment of Autonomy in Instrumental Activities of Daily Living in Dementia Patients by the Means of an Automatic Video Monitoring System. König A, Crispim-Junior CF, Covella AG, Bremond F, Derreumaux A, Bensadoun G, David R, Verhey F, Aalten P, Robert P. Front Aging Neurosci. 2015 Jun 2;7:98. doi: 10.3389/fnagi.2015.00098. eCollection 2015.
• The Role of Information and Communication Technologies in Clinical Trials with Patients with Alzheimer’s Disease and Related Disorders. König A, Sacco G, Bensadoun G, Bremond F, David R, Verhey F, Aalten P, Robert P, Manera V. Front Aging Neurosci. 2015 Jun 9;7:110. doi: 10.3389/fnagi.2015.00110. eCollection 2015. Review. No abstract available.
• Validation of an automatic video monitoring system for the detection of instrumental activities of daily living in dementia patients. König A, Crispim Junior CF, Derreumaux A, Bensadoun G, Petit PD, Bremond F, David R, Verhey F, Aalten P, Robert P. J Alzheimers Dis. 2015;44(2):675-85. doi: 10.3233/JAD-141767.
• Actigraphic motor activity in mild cognitive impairment patients carrying out short functional activity tasks: comparison between mild cognitive impairment with and without depressive symptoms. Yakhia M, König A, van der Flier WM, Friedman L, Robert PH, David R. J Alzheimers Dis. 2014;40(4):869-75. doi: 10.3233/JAD-131691. · 1 janv. 2014
• A review of current information and communication technologies: can they be used to assess apathy? König A, Aalten P, Verhey F, Bensadoun G, Petit PD, Robert P, David R. Int J Geriatr Psychiatry. 2014 Apr;29(4):345-58. doi: 10.1002/gps.4017. Epub 2013 Sep 5. Review. · 5 sept. 2013
• Phenotyping apathy in individuals with Alzheimer disease using functional principal component analysis. Zeitzer JM, David R, Friedman L, Mulin E, Garcia R, Wang J, Yesavage JA, Robert PH, Shannon W. Am J Geriatr Psychiatry. 2013 Apr;21(4):391-7. doi: 10.1016/j.jagp.2012.12.012. Epub 2013 Feb 6.
• Detection of activities of daily living impairment in Alzheimer’s disease and mild cognitive impairment using information and communication technology. Sacco G, Joumier V, Darmon N, Dechamps A, Derreumaux A, Lee JH, Piano J, Bordone N, Konig A, Teboul B, David R, Guerin O, Bremond F, Robert P. Clin Interv Aging. 2012;7:539-49. doi: 10.2147/CIA.S36297. Epub 2012 Dec 4.
• Automatic video monitoring system for assessment of Alzheimer’s disease symptoms. R. Romdhane, E. Mulin, A. Derreumeaux, N. Zouba, J. Piano, L. Lee, I. Leroi, P. Mallea, R. David, M. Thonnat, F. Bremond, PH. Robert. J Nutr Health Aging. 2012 Mar;16(3):213-8. · 1 mars 2012
• Circadian clock gene polymorphisms and sleep–wake disturbance in Alzheimer disease. Yesavage JA, Noda A, Hernandez B, Friedman L, Cheng JJ, Tinklenberg JR, Hallmayer J, O’hara R, David R, Robert P, Landsverk E, Zeitzer JM; Alzheimer’s Disease Neuroimaging Initiative. Am J Geriatr Psychiatry, 2011 Jul;19(7):635-43.
• Sleep Disordered Breathing in Vietnam Combat Veterans with Posttraumatic Stress Disorder. Yesavage JA., Kinoshita L., Kimball T., Zeitzer JM., Friedman L., Noda A., David R., Hernandez B., Cheng J., O’Hara R. Am J Geriatr Psychiatry, 2011 Jul;19(7):635-43.
• Decreased Daytime Motor Activity Associated With Apathy in Alzheimer Disease: An Actigraphic Study. David R, Mulin E, Friedman L, Le Duff F, Cygankiewicz E, Deschaux O, Garcia R, Yesavage J, Robert PH, Zeitzer J. Am J Geriatr Psychiatry, 2011
• Lack of Association Between COMT Polymorphisms and Apathy in Alzheimer’s Disease. David R, Friedman L, Mulin E, Noda A, Le Duff F, Kennedy Q, Garcia R, Robert PH, Yesavage JA, Zeitzer JM. J Alzheimers Dis. 2011;27(1):155-61.
• Relationship between Apathy and Sleep Disturbance in Mild and Moderate Alzheimer’s disease: An actigraphic study. Mulin E., Zeitzer JM., Friedman L., Duff FL., Yesavage J., Robert PH., David R. J Alzheimers Dis. 2011 Jan; 25(1):85-91.
• Ambulatory actigraphy correlates with apathy in mild Alzheimer’s disease. David R., Rivet R., Robert P.H., Mailland V., Friedman L., Zeitzer J., Yesavage J. Dementia. Published online before print September 21, 2010 doi: 10.1177/1471301210381678 · 21 sept. 2010
• Apathy diagnostic, assessment and treatment in Alzheimer’s disease. Robert PH., Mulin E., Malléa P., David R. CNS Neurosci Ther. 00 (2010) 1-9.
• Measurement of neuropsychiatric symptoms in clinical trials. David R., Mulin E., Malléa P., Robert PH. Pharmaceuticals, 2010, 3, 2387-2397.
• Non-pharmacologic management of sleep disturbances in Alzheimer’s disease. David R., Zeitzer JM., Friedman L., Noda A., O’Hara R., Robert PH., Yesavage JA. J Nutr Health Aging, 2010; 14(3):203-6
• Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction. David R., Koulibaly M., Benoit M., Garcia R., Caci H., Darcourt J., Robert P. Clin Neurol Neurosurg, 110 (1): 19-24, Jan 2007